RAFAEL HOLDINGS, INC. Other Comprehensive Income (Loss), Net of Tax
RAFAEL HOLDINGS, INC. (RFL) reported Other Comprehensive Income (Loss), Net of Tax of -$24.76 million for the 12-month period ending 2021-07-31, per its 10-K filed 2021-10-18.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2021-10-18
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), net of tax for the quarter ending 2020-07-31 was -$5.54M.
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), net of tax for the quarter ending 2020-04-30 was -$2.24M.
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), net of tax for the quarter ending 2019-04-30 was -$1.18M.
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), net of tax for fiscal 2021 was -$24.76M.
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), net of tax for fiscal 2020 was -$10.78M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2021-07-31 | -$24.76M 10-K · filed 2021-10-18 | |||
| 2020-07-31 | -$5.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | -$7.78M derived: sum of 2 quarters · filed 2021-10-18 | -$10.78M 10-K · filed 2021-10-18 | |
| 2020-04-30 | -$2.24M 10-Q · filed 2020-06-09 | -$5.24M 10-Q · filed 2020-06-09 | ||
| 2019-04-30 | -$1.18M 10-Q · filed 2020-06-09 | -$2.57M 10-Q · filed 2020-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |